In a report released today, Justin Smith from Bernstein maintained a Buy rating on AstraZeneca (AZN – Research Report), with a price target of ...

As per the reported property consultants, the company has issued a global mandate for selecting candidates for the said land ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

With the rising incidence of cancer in India, AstraZeneca India's breast cancer medicine trastuzumab deruxtecan (sold under ...

Shares of Vodafone Idea (Vi) dropped nearly 2 percent and are currently trading at around Rs 8.94 per share. The company is ...

Decision puts spotlight on Lord Hermer, who represented the former Sinn Fein leader in a separate compensation case ...

Pliant Therapeutics paused its phase 2b/3 trial of bexotegrast for idiopathic pulmonary fibrosis due to DSMB recommendations.

Policy Exchange attacks repeal of parts of Tories' Legacy Act, which removes a block on people like Gerry Adams seeking ...

The Policy Exchange has put the cost of inquiries, court cases, inquests and compensation payouts so far at between £840million and £1.4billion. It also estimates £1.3 billion will be incurred in the ...

Muddled purposes push main parties down in polls, with Tory leader’s biggest challenge being the Liberal Democrats ...